5 Best Small-Cap Value Stocks to Buy

Page 1 of 5

In this article, we will list the 5 Best Small-Cap Value Stocks to Buy. Please visit 10 Best Small-Cap Value Stocks to Buy if you would like to see the extended list and the methodology behind it.

5. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Forward P/E: 9.65

Market Cap: $1.87 Billion

Number of Hedge Fund Holders: 37

Stock Upside Potential: 37.45%

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best small-cap value stocks to buy. On April 24, H.C. Wainwright reiterated a Buy rating on Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) and a $55 price target.

The bullish stance is in response to positive discussions with the company’s senior management, including President and CEO Jeff Dayno, newly appointed CFO Glenn Reicin, and Head of Investor Relations Brennan Doyle. The discussions centered on patent infringement claims against AET Pharma and Sandoz.

5 Best Small-Cap Value Stocks to Buy

The patent in question covers new pitolisant formulations that expand IP protection for WAKIX beyond its pure crystalline polymorph formulation. Harmony Biosciences has already granted Novitum Pharma an exclusive license to manufacture its generic version of pitolisant, including an amorphous formulation.

Analysts at Oppenheimer have already raised Harmony Biosciences’ price target to $72 while maintaining an outperform rating, buoyed by the company’s strong patent portfolio. The company is also accelerating the development of Clemizole Hydrochloride (EPX-100) for the treatment of Dravet Syndrome and Lennox-Gastaut Syndrome.

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients with rare neurological diseases. Their primary product is WAKIX (pitolisant), a first-in-class medicine approved by the FDA for the treatment of excessive daytime sleepiness or cataplexy in adult patients with narcolepsy.

Page 1 of 5